GOGregorio T. Obrador

Gregorio T. Obrador

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gregorio T. Obrador has a total of 207 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Episiotomy Decision‐Making and Perceived Consequences: A Qualitative Study From Two Public Hospitals in Mexico

    by Ithandehui Jaimes‐Jiménez, Erika Sofia Valtierra‐Gutiérrez, Rodrigo A. González‐De Ita, Luis Ernesto Caballero‐Torres, Arturo González‐Ledesma, Liliana Dominguez‐Hernandez, Juan Manuel Mimiaga‐Morales, Mario I. Lumbreras‐Marquez, Gregorio T. Obrador, Lilia Elena Monroy‐Ramírez de Arellano

    Introduction: Episiotomy remains a widely performed procedure in many countries, despite international recommendations favoring a restrictive approach. In Mexico, high rates persist in several settings, including public hospitals. Understanding the factors that sustain this practice is key to designing evidence‐based respectful birth care strategies. This study aimed to explore healthcare professionals' perspectives on the decision‐making process, performance, and perceived consequences of episiotomy, and to engage them in the co‐design of behavioral science–informed interventions to promote its restrictive use. Methods: A two‐phase qualitative study was conducted in two public hospitals in Mexico, as part of a broader project aimed at promoting the restrictive use of episiotomy. In Phase 1, we conducted 22 semi‐structured interviews with maternal health care workers, selected through purposive sampling. Interviews were analyzed inductively using iterative coding and thematic grouping. In Phase 2, group interviews were conducted to discuss findings and collaboratively design interventions for a future pilot quasi‐experimental study. Results: Episiotomy decisions are often guided by clinical and preventive considerations. Non‐clinical factors, including productivity burdens and training, also contributed to the high rates of episiotomy. Despite the absence of formal institutional monitoring of episiotomy rates, professionals expressed a strong interest in receiving feedback and training. Conclusion: Episiotomy practices in this setting are influenced by clinical, systemic, and educational factors. Addressing potential overuse of episiotomy requires institutional feedback systems, evidence‐based training, and strategies to improve dignity in care. Engaging stakeholders through a participatory approach helps ensure that potential interventions are contextually relevant and feasible to implement.

  • Open Access

    Total Gestational Weight Gain Is Explained by Leptin and Body Fat, Regardless of Pre-Pregnancy Body Mass Index and Other Adipokines, in Mexican Adolescents

    by Gabriela Chico-Barba, Reyna Sámano, Hugo Martínez-Rojano, Rosa María Morales-Hernández, Edgar Barrientos-Galeana, Andrea Luna-Hidalgo, Martha Kaufer-Horwitz, Gregorio T. Obrador, Antonio Rafael Villa-Romero

    Pre-pregnancy body mass index (pBMI) is a predictor of gestational weight gain (GWG). However, other factors, such as adipokines and inflammation markers, may also be associated with GWG. The aim of the study was to determine the association of leptin, adiponectin, irisin, and C-reactive protein, with GWG in adolescents. A longitudinal study was conducted from 2018 to 2023 in adolescents with a clinically healthy pregnancy. The assessments included sociodemographic and clinical data, pBMI, percent of body fat, serum concentrations of leptin, adiponectin, irisin, and high-sensitivity C-reactive protein (hsCRP), and total GWG adequacy. Cox regression models were performed, the outcome variables were inadequate and excessive GWG. In 198 participants, being overweight/obesity was marginally associated with a protective effect against inadequate GWG (HR = 0.44, 95%CI = 0.18–1.06), regardless of maternal characteristics and adipokines. Leptin (HR = 1.014, 95%CI = 1.008–1.021), and body fat percent (HR = 1.11, 95%CI = 1.05–1.17) were associated with a higher risk of excessive GWG, independent of other maternal variables such as pBMI, while adiponectin was associated with a lower risk. These findings suggest that, in Mexican adolescents, adipose tissue and its adipokines during pregnancy may play a more significant role in the final GWG than body weight.


  • Top Cited Papers
    Open Access

    Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failure

    by Sara N. Davison, Wolfgang Pommer, Mark A. Brown, Claire A. Douglas, Samantha L. Gelfand, Irmingarda P. Gueco, Barnaby D. Hole, Sumiko Homma, Rümeyza T. Kazancıoğlu, Harumi Kitamura, et al.


  • Open Access

    Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

    by Iain C. Macdougall, Amy M. Meadowcroft, Allison Blackorby, Borut Cizman, Alexander R. Cobitz, Sergio Godoy, Vivekanand Jha, Kirsten L. Johansen, Gearoid McMahon, Gregorio T. Obrador, et al.

    Introduction: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) affects 10–15% of the chronic dialysis population. We explored baseline characteristics and predictors of ESA hyporesponsiveness in a global randomized cardiovascular outcomes study comparing an investigational hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), daprodustat, with conventional ESA treatment. Methods: ASCEND-D (NCT02879305) recruited 2,964 chronic dialysis patients receiving ESA treatment (standardized to weekly intravenous [IV] epoetin) who were iron replete at baseline. The primary ESA hyporesponsiveness definition was an ESA Resistance Index (ERI, ESA units/kg/week/hemoglobin g/L) ≥2 or IV standardized ESA dose ≥450 units/kg/week. Predictors of ESA hyporesponsiveness were determined using a multivariable regression model. Alternative hyporesponder definitions were explored. Results: Using the primary definition, 354 (12%) patients were ESA hyporesponsive. Geographic region, notably Latin America, lower baseline body mass index and transferrin saturation, younger age, lower albumin concentration, and a higher baseline IV iron dose were identified as strongly associated (p < 0.001) with ESA hyporesponsiveness. Additional predictors of ESA hyporesponsiveness included female sex (p = 0.010), history of heart failure (p = 0.035), longer dialysis vintage (p = 0.077), smoking status (p = 0.247), aspirin use (p = 0.121), and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use (p = 0.214). Conclusion: This is the first global HIF-PHI study to report prespecified definitions and predictors of ESA hyporesponsiveness. While most of the predictors identified in our study have been previously reported, geographic region stands out as an unexpected finding, meriting further investigation.


  • Open Access

    The environment and kidney health: challenges and opportunities

    by Joyita Bharati, Carol Zavaleta-Cortijo, Tiana Bressan, Aakash Shingada, Gregorio Obrador, Laura Sola, David Peiris, J Jaime Miranda, Vivekanand Jha

    The accelerating environmental degradation as a result of modernisation and climate change is an urgent threat to human health. Environment change can impact kidney health in a variety of ways such as water scarcity, global heating and changing biodiversity. Ever increasing industrialization of health care has a large carbon footprint, with dialysis being a major contributor. There have been calls for all stakeholders to adopt a ‘one health approach’ and develop mitigation and adaptation strategies to combat this challenge. Because of its exquisite sensitivity to various elements of environment change, kidney health can be a risk marker and a therapeutic target for such interventions. In this narrative review, we discuss the various mechanisms through which environmental change is linked to kidney health and the ways that the global kidney health communities can respond to environmental change.


  • Open Access

    Factors Associated With the Quality of the Patient-Doctor Relationship

    by Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Ana Belén Ortiz-Haro, Albert Christiaan Molewijk, Gregorio T. Obrador, Evandro Agazzi

    Background: The patient-doctor relationship (PDR) is a complex phenomenon with strong cultural determinants, which impacts health-related outcomes and, accordingly, does have ethical implications. The study objective was to describe the PDR from medical encounters between 600 Mexican outpatients with rheumatic diseases and their attending rheumatologists, and to identify factors associated with a good PDR. Methods: A cross-sectional study was performed. Patients completed the PDRQ-9 (Patient-Doctor Relationship Questionnaire, 9 items), the HAQ-DI (Health Assessment Questionnaire Disability Index), the Short-Form 36 items (SF-36), a pain–visual analog scale, and the Ideal Patient Autonomy Scale. Relevant sociodemographic, disease-related, and treatment-related variables were obtained. Patients assigned a PDRQ-9 score to each patient-doctor encounter. Regression analysis was used to identify factors associated with a good PDR, which was defined based on a cutoff point established using the borderline performance method. Results: Patients were primarily middle-aged female subjects (86%), with substantial disease duration (median, 11.1 years), without disability (HAQ-DI within reference range, 55.3%), and with deteriorated quality of life (SF-36 out of reference range, 73.7%–78.6%). Among them, 36.5% had systemic lupus erythematosus and 31.8% had rheumatoid arthritis. There were 422 patients (70.3%) with a good PDR and 523 medical encounters (87.2%) involved certified rheumatologists. Patient paternalistic ideal of autonomy (odds ratio [OR], 3.029; 95% confidence interval [CI], 1.793–5.113), SF-36 score (OR, 1.014; 95% CI, 1.003–1.025), female sex (OR, 0.460; 95% CI, 0.233–0.010), and being certified rheumatologist (OR, 1.526; 95% CI, 1.059–2.200) were associated with a good PDR. Conclusions: Patient-related factors and the degree of experience of the attending physician impact the quality of the PDR, in Mexican outpatients with rheumatic diseases.


  • Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives

    by Murilo Guedes, Bruce M. Robinson, Gregorio Obrador, Allison Tong, Ronald L. Pisoni, Roberto Pecoits-Filho

    In nondialysis CKD (ND-CKD), anemia is a multifactorial and complex condition in which several dysfunctions dynamically contribute to a reduction in circulating hemoglobin (Hb) levels in red blood cells. Anemia is common in CKD and represents an important and modifiable risk factor for poor clinical outcomes. Importantly, symptoms related to anemia, including reduced physical functioning and fatigue, have been identified as high priorities by patients with CKD. The current management of anemia in ND-CKD (i.e., parameters to initiate treatment, Hb and iron indexes targets, choice of therapies, and effect of treatment on clinical and patient-reported outcomes) remains controversial. In this review article, we explore the epidemiology of anemia in ND-CKD and revise current recommendations and controversies in its management. Exploring data from real-world clinical practices, particularly from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps), we highlight the current challenges to translating current recommendations to clinical practice, providing patients’ perspectives of anemia and how it affects their quality of life. Finally, we summarize recent advances in the field of anemia that may change the way this condition will be managed in the future.


  • Open Access

    Mismatch Between Kidney Disease Burden and Nephrology Workforce in Mexico

    by Gregorio T. Obrador, Sofía De Arrigunaga, Montserrat Cuadra, Antonio R. Villa